OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
3021
Results
Show all
Save search
Copy query
Show results for
Unknown
(2773)
Transcriptomics
(147)
Genomics
(46)
Proteomics
(40)
Metabolomics
(11)
Genomic
(2)
Models
(1)
Clinical
(1)
Multiomics
(1)
Organisms
Homo sapiens
(107)
Mus musculus
(39)
Andropogon gerardi
(33)
Bacteria
(33)
Canis lupus familiaris
(33)
Cnidaria
(33)
Eukaryota
(33)
Fasciola
(33)
Hepatitis B virus
(33)
Human alphaherpesvirus 1 strain 17
(33)
Human alphaherpesvirus 1 strain KOS
(33)
Human betaherpesvirus 5
(33)
Zea mays
(4)
Escherichia coli str. K-12 substr. MG1655
(4)
Enterococcus faecium
(3)
Dichelobacter nodosus
(2)
Pseudomonas aeruginosa
(2)
Drosophila melanogaster
(2)
Arabidopsis thaliana
(2)
Saccharomyces cerevisiae SK1
(1)
Shewanella oneidensis
(1)
Pseudomonas syringae pv. tomato str. DC3000
(1)
Hydra vulgaris
(1)
Pan troglodytes
(1)
Clostridium acetobutylicum
(1)
Glycine max
(1)
Mycobacterium tuberculosis H37Rv
(1)
Plasmodium falciparum
(1)
Saccharomyces cerevisiae
(1)
Danio rerio
(1)
Organisms
Homo sapiens
(9)
Mus musculus
(3)
Repository
biostudies-arrayexpress
(162)
pride
(33)
EGA
(16)
ENA
(13)
MetaboLights
(11)
MassIVE
(7)
dbGaP
(2)
geo
(2)
BioModels
(1)
Tissue
Cell culture
(6)
Epithelial cell
(3)
Blood
(2)
Leukocyte
(2)
Lung
(2)
B cell
(1)
Blood plasma
(1)
Bone marrow
(1)
Carcinoma cell
(1)
Colon
(1)
Epithelial cell of lung
(1)
Epithelial cell of skin gland
(1)
Heart
(1)
Liver
(1)
Logarithmic phase culture
(1)
Neoplastic cell
(1)
Neutrophil
(1)
Pancreas
(1)
Pancreatic ductal cell
(1)
Permanent cell line cell
(1)
Primary cell
(1)
Prostate cancer cell line
(1)
Prostate gland
(1)
Small intestine
(1)
Spleen
(1)
T cell
(1)
Testis
(1)
Tooth
(1)
Whole body
(1)
Disease
Acute leukemia
(2)
Breast cancer
(2)
Aorta aneurysm
(1)
Schizophrenia
(1)
Microsatellite stable (MSS) metastatic colorectal cancer (mCRC)
(1)
Ataxia telangiectasia
(1)
Colon cancer
(1)
Kidney cancer
(1)
Lung adenocarcinoma
(1)
Lung cancer
(1)
Melanomatosis
(1)
Neutropenia
(1)
Pancreatic carcinoma
(1)
Pancreatic ductal adenocarcinoma
(1)
Systemic mastocytosis
(1)
Ulcerative colitis
(1)
Technology Type
Mass Spectrometry
(33)
Shotgun proteomics
(16)
Mass spectrometry
(10)
Bottom-up proteomics
(8)
Data-dependent acquisition
(3)
SWATH MS
(3)
Illumina HiSeq 2000
(2)
Data-independent acquisition
(2)
Complete Genomics (COMPLETE_GENOMICS)
(1)
Illumina Genome Analyzer II, Illumina HiSeq 2000
(1)
NMR spectroscopy
(1)
Mass spectrometry assay
(1)
Affinity purification coupled with mass spectrometry proteomics
(1)
Chemical cross-linking coupled with mass spectrometry proteomics
(1)
Gel-based experiment
(1)
MSE
(1)
Top-down proteomics
(1)
Instrument Platform
Liquid Chromatography MS - negative - reverse phase
(6)
Illumina NovaSeq 6000
(4)
Liquid Chromatography MS - positive - reverse phase
(4)
Illumina HiSeq 2500
(3)
Gene Titan
(2)
Illumina HiSeq 4000
(2)
Q Exactive
(2)
Affymetrix Gene Titan
(1)
Illumina HiSeq 2000
(1)
LTQ Orbitrap Elite
(1)
Orbitrap Fusion Lumos
(1)
Q Exactive Plus
(1)
Q-Exactive
(1)
QExactive HFX
(1)
TripleTOF 5600
(1)
Liquid Chromatography MS - alternating – hilic
(1)
Liquid Chromatography Tandem MS (LC-MS/MS)
(1)
Liquid Chromatography MS - Alternating (LC-MS (Alt))
(1)
Direct infusion MS - positive
(1)
API 4000 QTRAP (AB Sciex)
(1)
Nuclear Magnetic Resonance (NMR) -
(1)
Publication Date
2013
(38)
2010
(33)
2012
(16)
2011
(15)
2014
(12)
2016
(10)
2025
(9)
2015
(9)
2024
(9)
2026
(7)
2009
(7)
2023
(6)
2020
(6)
2018
(6)
2008
(6)
2007
(6)
2019
(6)
2022
(5)
2021
(5)
2017
(2)
2006
(2)
2004
(1)
CHEBI ID
CHEBI:72959
(3)
CHEBI:28875
(3)
CHEBI:28842
(3)
CHEBI:15756
(3)
CHEBI:64563
(3)
CHEBI:72522
(2)
CHEBI:85682
(2)
CHEBI:132724
(2)
CHEBI:138567
(2)
CHEBI:180469
(2)
CHEBI:140360
(2)
CHEBI:156040
(2)
CHEBI:85759
(2)
CHEBI:72530
(2)
CHEBI:72510
(2)
CHEBI:134490
(2)
CHEBI:85686
(2)
CHEBI:85683
(2)
CHEBI:137554
(2)
CHEBI:85692
(2)
CHEBI:136288
(2)
CHEBI:72513
(2)
CHEBI:85698
(2)
CHEBI:86980
(2)
CHEBI:86974
(2)
CHEBI:85688
(2)
CHEBI:138568
(2)
CHEBI:138566
(2)
CHEBI:136239
(2)
CHEBI:140362
(2)
Metabolite Name
CE(17:1)
(2)
CE(16:1)
(2)
LysoPE(0:0/20:5(5Z,8Z,11Z,14Z,17Z))
(2)
Cer(d18:1/14:0)
(2)
LysoPE(16:0/0:0)
(2)
3-Dehydroxycarnitine
(2)
LysoPC(20:4(5Z,8Z,11Z,14Z))
(2)
LysoPC(22:6(4Z,7Z,10Z,13Z,16Z,19Z))
(2)
N-Palmitoylsphingosine
(2)
LysoPE(0:0/18:3(6Z,9Z,12Z))
(2)
LysoPE(18:1(9Z)/0:0)
(2)
Glutathione
(2)
5-Hydroxyindoleacetic acid
(2)
LysoPE(16:1(9Z)/0:0)
(2)
Asymmetric dimethylarginine
(2)
Creatine
(2)
Glycerophosphocholine
(2)
Hypoxanthine
(2)
8-iso-PGF2a-III
(1)
PC(30:1)
(1)
DG(40:4)
(1)
DG(40:5)
(1)
DG(40:7)
(1)
DG(38:0)
(1)
DG(38:1)
(1)
DG(38:2)
(1)
DG(38:3)
(1)
DG(38:4)
(1)
DG(36:0)
(1)
DG(36:1)
(1)
IsPrivate
False
(1)
First Public Date
2026
(6)
2024
(2)
2025
(1)
2021
(1)
2020
(1)
2014
(1)
2013
(1)
Modelling Approach
Differential equation model
(1)
Study status
Active, not recruiting
(1)
Study type
Transcription profiling by array
(75)
RNA-seq of coding RNA
(25)
ChIP-seq
(15)
Methylation profiling by array
(13)
ChIP-chip by tiling array
(12)
Unknown experiment type
(5)
Comparative genomic hybridization by array
(5)
RNA-seq of non coding RNA
(3)
Other
(2)
RNA-seq of coding RNA from single cells
(2)
Methylation profiling by high throughput sequencing
(2)
Human - Single-cell sequencing
(1)
ATAC-seq
(1)
Hi-C
(1)
Interventional
(1)
Release Date
2022
(330)
2021
(300)
2025
(261)
2024
(259)
2023
(257)
2020
(247)
2018
(171)
2019
(152)
2016
(133)
2017
(122)
2015
(121)
2013
(116)
2012
(85)
2014
(84)
2011
(75)
2010
(70)
2009
(41)
2026
(38)
2008
(24)
2007
(16)
2006
(11)
2004
(10)
2005
(4)
2003
(3)
2002
(2)
1998
(2)
1999
(1)
Lab affiliation
Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, 792 Elizabeth Street, Melbourne, VIC 3000, Australia.
(3)
1VIB Center for Medical Biotechnology, VIB, Ghent, 9052, Belgium 2Department of Biomolecular Medicine, Ghent University, Ghent, 9052, Belgium
(2)
1 VIB Center for Medical Biotechnology, VIB, Ghent, East Flanders, 9052, Belgium 2 Department of Biomolecular Medicine, Ghent University, Ghent, East Flanders, 9052, Belgium
(1)
Associate Professor of Biochemistry Associate Professor of Cell Biology Duke University School of Medicine
(1)
Baxter Laboratory for Stem Cell Biology Department of Microbiology & Immunology Stanford University School of Medicine 269 Campus Drive CCSR 3205b Stanford, CA 94305-5175, USA
(1)
Bristol-Myers Squibb, USA
(1)
Department of Biochemistry Geisel School of Medicine at Dartmouth
(1)
Department of Chemistry, Imperial College London, United Kingdom
(1)
Department of Glycobiology, Institute of Chemistry, Slovak Academy of Sciences
(1)
Department of Immunology, University of Pittsburgh
(1)
Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, OR USA
(1)
Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA
(1)
Deputy Head of School, School of Biological Sciences | 19 Chlorine Gardens| Belfast, BT9 5DJ Queen’s University Belfast | +44 28 9097 2383 | https://www.qub.ac.uk/schools/SchoolofBiologicalSciences/
(1)
Institute of Biochemistry II, Goethe University, Frankfurt, Germany
(1)
MRC Toxicology Unit, University of Cambridge
(1)
Member, St. Jude Faculty / Director, Division of Experimental Hematology / Wall Street Committee Endowed Chair St. Jude Children's Reserch Jospital Memphis, TN 38105
(1)
Oncology Research and Development, Pfizer Inc.
(1)
Physiology and Pharmacology McCaig Institute Southern Alberta Mass Spectrometry Core facility University of Calgary
(1)
Professor of Biomolecular Chemistry at the University of Wisconsin - Madison
(1)
Proteomics Platform, Broad Institute of MIT and Harvard
(1)
Senior Researcher - Principal Investigator, Computational and Chemical Biology, Istituto Italiano di Tecnologia Via Morego, 30 16163 Genova - Italy Tel: +39 010 28961 - C.F.: 97329350587 - P.Iva: 09198791007
(1)
Systems Biology Ireland, University College Dublin.
(1)
The David and Inez Myers Laboratory of Cancer Genetics, Department of Human Molecular Genetics and Biochemistry, Tel Aviv University School of Medicine, Tel Aviv 69987, Israel.
(1)
The Forsyth Institute
(1)
The Institute of Cancer Research
(1)
The University of Queensland
(1)
Thoracic and GI Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, MD 20892, USA 7Present address: Bristol Myers Squibb, Lawrenceville, NJ 08901, USA and Thoracic and GI Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, MD 20892, USA.
(1)
UC Proteomics Laboratory, Department of Cancer Biology, University of Cincinnati College of Medicine, Cincinnati, Ohio, Unite States
(1)
University of California San Diego
(1)
University of Maryland - College Park Molecular & Cellular Biology
(1)
Location
United States
(1)
Japan
(1)
Tags
xref:PubMed:35020601
(1)
xref:PubMed:20643877
(1)
xref:PubMed:42498680
(1)
xref:PubMed:22561152
(1)
xref:PubMed:39117654
(1)
xref:PubMed:34295332
(1)
xref:PubMed:33847741
(1)
Previous
page
1 / 303
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
303
Next
page
Sort
by:
Relevance
Page size
10
Exploring the Psychosocial Influences on Hepatitis B and Liver Cancer Disparities.
Not available
S-EPMC12424198
|
biostudies-literature
Cite
Data-driven strategies for increasing patient diversity in Bristol Myers Squibb-sponsored US oncology clinical trials.
Not available
S-EPMC10638849
|
biostudies-literature
Cite
Retrospective Comparison of Survival Projections for CAR T-Cell Therapies in Large B-Cell Lymphoma.
Not available
S-EPMC10721757
|
biostudies-literature
Cite
Mucosal B Cell Expansion and Maturation Contribute to Colitis Pathogenesis.
Not available
S-EPMC12857420
|
biostudies-literature
Cite
Economic burden in treated Japanese patients with relapsed/refractory large B-cell lymphoma.
Not available
S-EPMC8386473
|
biostudies-literature
Cite
Cost drivers associated with diffuse large B-cell lymphoma (DLBCL) in Japan: A structural equation model (SEM) analysis.
Not available
S-EPMC9140275
|
biostudies-literature
Cite
BET inhibitor trotabresib in heavily pretreated patients with solid tumors and diffuse large B-cell lymphomas.
Not available
S-EPMC10011554
|
biostudies-literature
Cite
Access to Chimeric Antigen Receptor T Cell Therapy for Diffuse Large B Cell Lymphoma.
Not available
S-EPMC8408091
|
biostudies-literature
Cite
Phase 2 results of lisocabtagene maraleucel in Japanese patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma.
Not available
S-EPMC9761090
|
biostudies-literature
Cite
Interleukin-21 enhances rituximab activity in a cynomolgus monkey model of B cell depletion and in mouse B cell lymphoma models.
Not available
S-EPMC3692496
|
biostudies-literature
Cite
Previous
page
1 / 303
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
303
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets